Psychiatric Genomics, Inc. Company Profile

21:50 EDT 24th March 2018 | BioPortfolio

Dr. C. Anthony Altar is President and Chief Scientific Officer at Psychiatric Genomics. His research team is responsible for gene discovery, medicinal chemistry, and drug discovery efforts. Dr. Altar has published 120 articles in peer-reviewed journals that include Science, Nature, PNAS, and the Burger’s Medicinal Chemistry series. He pioneered methods for receptor localization using computerized image analysis and discovered the serotonin/ dopamine receptor binding patterns of antipsychotic drugs, which typify the atypical antipsychotics now in use. His team at Regeneron identified brain actions of neurotrophic factors, including roles in human depression, now an experimental clinical approach. As Director for Global Neuroscience Research at Otsuka America Pharmaceuticals, Dr. Altar led the team that discovered and co-developed aripiprazole (Abilify), recently FDA-approved.


19 Firstfield Rd.
United States of America


Phone: 301.556.1300
Fax: 301.556.1350

News Articles [423 Associated News Articles listed on BioPortfolio]

Improved ethical guidance for the return of results from psychiatric genomics research

I was attacked by a patient and want my fear to help others

I have been working with psychiatric patients for the better part of 30 years. During this time, I have worked in psychiatric emergency rooms, prison wards, substance abuse treatment centers and inpat...

Berry Genomics Collaborates with 10X Genomics for Next-Gen Prenatal Tests

Berry Genomics of Beijing will collaborate with California's 10X Genomics to develop next-gen noninvasive prenatal tests (NIPT). Specifically, the companies will incorporate 10X's haplotype genomic in...

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces the appointment of its first Chief Executive Officer (CEO) today. Global genomics pioneer Professor John Mattick will join Genomics England in June. He will lead the organiz...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

Nebula wants to democratise genome sequencing, with the help of blockchain and cryptocurrency

A new start-up has been launched with a dazzling, technology-enabled vision of putting genomics into the hands of the DNA’s owners – individuals – rather than what it calls genomics ‘middle me...

Rosetta Genomics Ltd.: Genoptix to Acquire Rosetta Genomics for $10 Million in Cash

The value to Rosetta Genomics' equity holders is preliminarily estimated to be $0.60 per ordinary share, after deductions for debt, warrant termination payments, fees, expenses and other items CAR...

HL7 Meeting to Focus on Intersection of Clinical Genomics, AI

David RathsGrant Wood, a member of the HL7 Clinical Genomics Work Group and a senior strategist at Intermountain Healthcare’s Clinical Genetics Institute, talks about the confluence of genomics and ...

Drugs and Medications [94 Associated Drugs and Medications listed on BioPortfolio]

Lisinopril [Aurobindo Pharma Limited]

Citalopram [International Labs, Inc.]


Mirtazapine [Aurolife Pharma LLC]

Mirtazapine Tablets, USP7.5 mg, 15 mg, 30 mg, and 45 mg Rx Only

Mirtazapine [H.J. Harkins Company, Inc.]

Mirtazapine Tablets, USP30 mg Rx Only

Mirtazapine [Bryant Ranch Prepack]

Mirtazapine Tablets, USP 45 mg

PubMed Articles [917 Associated PubMed Articles listed on BioPortfolio]

Genomics Education: Knowledge of Nurses Across the Profession and Integration Into Practice.

Since the completion of the Human Genome Project in 2003, the implications of genetics and genomics for health and illness have become clearer. All nurses, at all levels and across all specialties, mu...

psygenet2r: a R/Bioconductor package for the analysis of psychiatric disease genes.

Psychiatric disorders have a great impact on morbidity and mortality. Genotype-phenotype resources for psychiatric diseases are key to enable the translation of research findings to a better care of p...

Cochlear Implants and Psychiatric Assessments: a Norrie Disease Case Report.

It is important to perform psychiatric assessments of adult patients who are candidates for cochlear implants both to screen them for psychiatric disorders and to assess their understanding and compli...

Recent developments of software and database in microbial genomics and functional genomics.

Improved Metabolic and Psychiatric Outcomes with Discontinuation of Atypical Antipsychotics in Youth Hospitalized in a State Psychiatric Facility.

To assess the impact of antipsychotic tapering and discontinuation on measures of metabolic functioning and psychiatric symptom severity in severely impaired youth hospitalized in a psychiatric state ...

Clinical Trials [724 Associated Clinical Trials listed on BioPortfolio]

Treatment for Psychological and Drug Abuse Problems

The purpose of the study is to evaluate methods to help people in substance abuse treatment receive better psychiatric care. Patients enrolled in the study will be offered three months of...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Somatic Comorbidities in Psychiatric Patients

Prevalence of somatic comorbidities in psychiatric patients hospitalized in Psychiatric hospital or treated ambulatory or in daily hospital. Comparison of prevalence of somatic comorbiditi...

Mood and Anti-Craving Effects of Varenicline in Psychiatric Inpatients

This study of psychiatric inpatients will assess mood effects of varenicline, as well as assess if varenicline decreased nicotine cravings acutely. This study will also measure side effec...

Psychiatric Day Hospital Treatment

The aim of the study was to compare the effectiveness of acute psychiatric day care to conventional inpatient care within a cross-national multi-site randomised controlled trial.

Companies [504 Associated Companies listed on BioPortfolio]

Psychiatric Solutions, Inc. (PSI)

Psychiatric Solutions, Inc. offers an extensive continuum of behavioral health programs to critically ill children, adolescents and adults and is the largest operator of owned or ...

Psychiatric Solutions, Inc.

Psychiatric Solutions, Inc. offers an extensive continuum of behavioral health programs to critically ill children, adolescents and adults and is the largest operator of owned or ...

Psychiatric Genomics, Inc.

Dr. C. Anthony Altar is President and Chief Scientific Officer at Psychiatric Genomics. His research team is responsible for gene discovery, medicinal chemistry, and drug discovery efforts. Dr. Altar ...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "Psychiatric Genomics, Inc." on BioPortfolio

We have published hundreds of Psychiatric Genomics, Inc. news stories on BioPortfolio along with dozens of Psychiatric Genomics, Inc. Clinical Trials and PubMed Articles about Psychiatric Genomics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Psychiatric Genomics, Inc. Companies in our database. You can also find out about relevant Psychiatric Genomics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record